Opens in a new tab

FOX13 Seattle discusses Scalp Cooling with former Paxman Patient Rachel Kayla

During the segment Rachel, who now supports healthcare facilities across the U.S. in the implementation of Paxman Scalp Cooling, described the impact that retaining 70% of her hair had on her personally during her own chemotherapy treatment for breast cancer, which she completed in April 2021.

Rachel now regularly advocates for others facing a similar diagnosis, to help them maintain a degree of normalcy by using scalp cooling to mitigate against chemotherapy-induced hair loss during cancer treatment.

Access the full interview here.

Related articles

California Enacts Landmark Scalp Cooling Coverage Legislation 

Posted: September 28, 2026
Read article

A True Team Effort: The Importance Of Family Support In The Scalp Cooling Journey. 

Posted: September 24, 2026
Read article

Paxman set to receive funding from Innovate UK 

Posted: September 10, 2026
Read article
Get the Paxman System

Wherever you are in the world, it’s easy to give patients access to our chemotherapy side effect management solutions and a degree of control. Fill out the form to get started.

Get Paxman in your country with our global locator